AAPL283.98+2.24 (+0.79%) ▲|ABBV252.87-1.44 (-0.57%) ▼|ABT92.35-0.36 (-0.39%) ▼|ACN123.06-1.68 (-1.35%) ▼|ADBE204.11-2.32 (-1.12%) ▼|AMAT719.79+25.15 (+3.62%) ▲|AMD549.63+10.14 (+1.88%) ▲|AMGN360.37-0.18 (-0.05%) ▼|AMT164.83-3.84 (-2.28%) ▼|AMZN239.40-0.74 (-0.31%) ▼|AVGO376.18+3.73 (+1.00%) ▲|AXP343.60+2.81 (+0.82%) ▲|BA216.23+1.56 (+0.73%) ▲|BAC57.18-0.70 (-1.20%) ▼|BKNG181.06-1.35 (-0.74%) ▼|BLK958.70+8.86 (+0.93%) ▲|BMY58.00-0.55 (-0.94%) ▼|BNY144.54+0.79 (+0.55%) ▲|BRK-B496.53+0.60 (+0.12%) ▲|C141.31-1.22 (-0.85%) ▼|CAT1,051.77+19.17 (+1.86%) ▲|CL91.64-0.74 (-0.80%) ▼|CMCSA24.82+0.60 (+2.48%) ▲|COF204.16+1.98 (+0.98%) ▲|COP103.92-0.28 (-0.27%) ▼|COST943.46-3.22 (-0.34%) ▼|CRM156.50-1.48 (-0.93%) ▼|CSCO118.07+0.37 (+0.31%) ▲|CVS102.99-0.59 (-0.57%) ▼|CVX167.91-0.56 (-0.33%) ▼|DE623.55-1.46 (-0.23%) ▼|DHR191.37-1.42 (-0.73%) ▼|DIS97.01-0.88 (-0.89%) ▼|DUK126.87-1.46 (-1.14%) ▼|EMR142.43-0.40 (-0.28%) ▼|FDX320.24-5.17 (-1.59%) ▼|GD349.21+1.14 (+0.33%) ▲|GE376.13+2.42 (+0.65%) ▲|GEV1,117.17+14.66 (+1.33%) ▲|GILD125.55-0.78 (-0.62%) ▼|GM77.01-0.33 (-0.43%) ▼|GOOG349.79-1.49 (-0.42%) ▼|GOOGL351.81-1.84 (-0.52%) ▼|GS1,016.28-3.93 (-0.39%) ▼|HD350.35-0.47 (-0.13%) ▼|HON227.26-0.54 (-0.24%) ▼|IBM275.70-2.30 (-0.83%) ▼|INTC134.85+3.13 (+2.38%) ▲|INTU264.76-1.65 (-0.62%) ▼|ISRG399.73-6.25 (-1.54%) ▼|JNJ256.53-1.99 (-0.77%) ▼|JPM328.55-0.85 (-0.26%) ▼|KO81.68-0.97 (-1.17%) ▼|LIN516.83+5.77 (+1.13%) ▲|LLY1,215.00-14.93 (-1.21%) ▼|LMT502.50+0.43 (+0.09%) ▲|LOW218.47-1.18 (-0.54%) ▼|LRCX433.07+22.16 (+5.39%) ▲|MA511.45+1.81 (+0.36%) ▲|MCD268.17+0.99 (+0.37%) ▲|MDLZ59.38-0.77 (-1.28%) ▼|MDT79.40-1.53 (-1.89%) ▼|META557.09-5.51 (-0.98%) ▼|MMM163.60+1.17 (+0.72%) ▲|MO73.47-0.58 (-0.78%) ▼|MRK128.38-1.01 (-0.78%) ▼|MS209.96-1.77 (-0.83%) ▼|MSFT372.00+3.43 (+0.93%) ▲|MU1,137.89-7.39 (-0.65%) ▼|NEE87.61-1.05 (-1.18%) ▼|NFLX73.43-0.35 (-0.47%) ▼|NKE41.16-0.32 (-0.77%) ▼|NOW98.42-1.56 (-1.56%) ▼|NVDA196.57+1.60 (+0.82%) ▲|ORCL148.27+0.51 (+0.35%) ▲|PEP138.38-0.30 (-0.22%) ▼|PFE24.11-0.26 (-1.08%) ▼|PG145.48-2.97 (-2.00%) ▼|PLTR116.19+0.49 (+0.42%) ▲|PM181.83-1.05 (-0.57%) ▼|QCOM187.09-1.63 (-0.86%) ▼|RTX189.04+1.71 (+0.91%) ▲|SBUX104.41+0.35 (+0.34%) ▲|SCHW93.24+2.69 (+2.97%) ▲|SO95.86-0.89 (-0.92%) ▼|SPG224.75-2.77 (-1.22%) ▼|T21.23-0.57 (-2.59%) ▼|TMO500.70-5.57 (-1.10%) ▼|TMUS169.11-4.87 (-2.80%) ▼|TSLA411.56-0.28 (-0.07%) ▼|TXN291.61+6.13 (+2.15%) ▲|UBER74.63-0.83 (-1.09%) ▼|UNH414.70-4.80 (-1.14%) ▼|UNP270.00-2.76 (-1.01%) ▼|UPS107.72-0.24 (-0.22%) ▼|USB60.67-0.59 (-0.96%) ▼|V341.34-0.35 (-0.10%) ▼|VZ43.06-1.01 (-2.30%) ▼|WFC83.26-0.24 (-0.29%) ▼|WMT113.92-0.68 (-0.59%) ▼|XOM135.63-0.41 (-0.30%) ▼|AAPL283.98+2.24 (+0.79%) ▲|ABBV252.87-1.44 (-0.57%) ▼|ABT92.35-0.36 (-0.39%) ▼|ACN123.06-1.68 (-1.35%) ▼|ADBE204.11-2.32 (-1.12%) ▼|AMAT719.79+25.15 (+3.62%) ▲|AMD549.63+10.14 (+1.88%) ▲|AMGN360.37-0.18 (-0.05%) ▼|AMT164.83-3.84 (-2.28%) ▼|AMZN239.40-0.74 (-0.31%) ▼|AVGO376.18+3.73 (+1.00%) ▲|AXP343.60+2.81 (+0.82%) ▲|BA216.23+1.56 (+0.73%) ▲|BAC57.18-0.70 (-1.20%) ▼|BKNG181.06-1.35 (-0.74%) ▼|BLK958.70+8.86 (+0.93%) ▲|BMY58.00-0.55 (-0.94%) ▼|BNY144.54+0.79 (+0.55%) ▲|BRK-B496.53+0.60 (+0.12%) ▲|C141.31-1.22 (-0.85%) ▼|CAT1,051.77+19.17 (+1.86%) ▲|CL91.64-0.74 (-0.80%) ▼|CMCSA24.82+0.60 (+2.48%) ▲|COF204.16+1.98 (+0.98%) ▲|COP103.92-0.28 (-0.27%) ▼|COST943.46-3.22 (-0.34%) ▼|CRM156.50-1.48 (-0.93%) ▼|CSCO118.07+0.37 (+0.31%) ▲|CVS102.99-0.59 (-0.57%) ▼|CVX167.91-0.56 (-0.33%) ▼|DE623.55-1.46 (-0.23%) ▼|DHR191.37-1.42 (-0.73%) ▼|DIS97.01-0.88 (-0.89%) ▼|DUK126.87-1.46 (-1.14%) ▼|EMR142.43-0.40 (-0.28%) ▼|FDX320.24-5.17 (-1.59%) ▼|GD349.21+1.14 (+0.33%) ▲|GE376.13+2.42 (+0.65%) ▲|GEV1,117.17+14.66 (+1.33%) ▲|GILD125.55-0.78 (-0.62%) ▼|GM77.01-0.33 (-0.43%) ▼|GOOG349.79-1.49 (-0.42%) ▼|GOOGL351.81-1.84 (-0.52%) ▼|GS1,016.28-3.93 (-0.39%) ▼|HD350.35-0.47 (-0.13%) ▼|HON227.26-0.54 (-0.24%) ▼|IBM275.70-2.30 (-0.83%) ▼|INTC134.85+3.13 (+2.38%) ▲|INTU264.76-1.65 (-0.62%) ▼|ISRG399.73-6.25 (-1.54%) ▼|JNJ256.53-1.99 (-0.77%) ▼|JPM328.55-0.85 (-0.26%) ▼|KO81.68-0.97 (-1.17%) ▼|LIN516.83+5.77 (+1.13%) ▲|LLY1,215.00-14.93 (-1.21%) ▼|LMT502.50+0.43 (+0.09%) ▲|LOW218.47-1.18 (-0.54%) ▼|LRCX433.07+22.16 (+5.39%) ▲|MA511.45+1.81 (+0.36%) ▲|MCD268.17+0.99 (+0.37%) ▲|MDLZ59.38-0.77 (-1.28%) ▼|MDT79.40-1.53 (-1.89%) ▼|META557.09-5.51 (-0.98%) ▼|MMM163.60+1.17 (+0.72%) ▲|MO73.47-0.58 (-0.78%) ▼|MRK128.38-1.01 (-0.78%) ▼|MS209.96-1.77 (-0.83%) ▼|MSFT372.00+3.43 (+0.93%) ▲|MU1,137.89-7.39 (-0.65%) ▼|NEE87.61-1.05 (-1.18%) ▼|NFLX73.43-0.35 (-0.47%) ▼|NKE41.16-0.32 (-0.77%) ▼|NOW98.42-1.56 (-1.56%) ▼|NVDA196.57+1.60 (+0.82%) ▲|ORCL148.27+0.51 (+0.35%) ▲|PEP138.38-0.30 (-0.22%) ▼|PFE24.11-0.26 (-1.08%) ▼|PG145.48-2.97 (-2.00%) ▼|PLTR116.19+0.49 (+0.42%) ▲|PM181.83-1.05 (-0.57%) ▼|QCOM187.09-1.63 (-0.86%) ▼|RTX189.04+1.71 (+0.91%) ▲|SBUX104.41+0.35 (+0.34%) ▲|SCHW93.24+2.69 (+2.97%) ▲|SO95.86-0.89 (-0.92%) ▼|SPG224.75-2.77 (-1.22%) ▼|T21.23-0.57 (-2.59%) ▼|TMO500.70-5.57 (-1.10%) ▼|TMUS169.11-4.87 (-2.80%) ▼|TSLA411.56-0.28 (-0.07%) ▼|TXN291.61+6.13 (+2.15%) ▲|UBER74.63-0.83 (-1.09%) ▼|UNH414.70-4.80 (-1.14%) ▼|UNP270.00-2.76 (-1.01%) ▼|UPS107.72-0.24 (-0.22%) ▼|USB60.67-0.59 (-0.96%) ▼|V341.34-0.35 (-0.10%) ▼|VZ43.06-1.01 (-2.30%) ▼|WFC83.26-0.24 (-0.29%) ▼|WMT113.92-0.68 (-0.59%) ▼|XOM135.63-0.41 (-0.30%) ▼|
23.7 C
New York
Tuesday, June 30, 2026

Tag: value

newssourceFORcompanyinformationcontent1releasesmarket

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027

He Predicted Gold at $5,000. Now He Says This $2 Stock Could Be Even Bigger.

A former CIA and Pentagon advisor says Trump is weeks away from unlocking the largest untapped mineral deposit in the United States 
A former CIA and Pentagon advisor says Trump is weeks away from unlocking the largest untapped mineral deposit in the United States

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Company announcement No. 21 / 2026

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting...

Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and SYNCHRONIZE-MASLD.2,4 The results demonstrate survodutide’s potential to reduce weight and therefore improve metabolic health in two distinct populations: adults living with obesity or overweight, without type 2 diabetes (SYNCHRONIZE-1),2 and adults with overweight or obesity with metabolic dysfunction-associated steatotic liver disease (MASLD) with evidence of inflammation and or fibrosis (SYNCHRONIZE-MASLD).4 Full results from SYNCHRONIZE-1 and SYNCHRONIZE-MASLD were presented today at the American Diabetes Association’s (ADA) 2026 Scientific Sessions and published simultaneously in The New England Journal of Medicine and Nature Medicine respectively.5,6

IBA‑UIBC Cup of Bakers 2027 “Golden Statue Cup” China Selection – Hong Kong & Macao SAR Selection Competition Successfully Held in Hong Kong

Competition Highlights Industry Excellence and Strengthens International Exchange in the Baking Sector HONG KONG, June 7, 2026 /PRNewswire/ -- The Final of the IBA‑UIBC Cup...

Unlocking the Americas: Air Canada and Abra Group Sign Memorandum to Expand Travel and Connectivity between Canada, Latin America and Beyond

RIO DE JANEIRO, June 07, 2026 (GLOBE NEWSWIRE) -- Air Canada and Abra Group today announced they have signed a Memorandum of Understanding to develop a broad, long-term strategic partnership. The agreement between Canada’s largest airline and the Latin American air transport company, whose carriers include the Avianca and GOL brands, would enable the partners to expand their global reach, providing customers and shippers greater connectivity across North, Central and South America and beyond. Any final agreement is subject to final documentation and regulatory approval.

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk...

Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of the strongest US pharmaceutical launches by...

Unlocking the Americas: Air Canada and Abra Group Sign Memorandum to Expand Travel and Connectivity between Canada, Latin America and Beyond

Establishes pathway to strategic partnership of Air Canada and Abra Group and a joint business agreement Customers will benefit from an improved travel experience,...

Vision Insurance After Retirement (2026): VSP Vision Care Named Leading Option for Retiree Eye Coverage by Expert Consumers

NEW YORK, June 7, 2026 /PRNewswire/ -- A recent analysis from Expert Consumers highlights VSP® Vision Care as a leading option for vision insurance...

Duke Energy offers tips to save energy and money as temperatures rise in the Carolinas

What's happening: Temperatures are forecast to reach the 90s, pushing cooling systems to run longer and use more energy to maintain indoor temperaturesWhy it...

Communiqué Orange : Orange signs a joint agreement to acquire SFR, a decisive step that will reinforce its leadership in France

Press release
Paris, 6 June 2026

Communiqué Orange : Signing of a Memorandum of Understanding for the acquisition of SFR

Press release
Paris, 6 June 2026

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance 

University of Phoenix researchers publish study examining doctoral students’ attitudes toward AI chatbots and ChatGPT use in higher education

Peer-reviewed study by Center for Educational and Instructional Technology Research team highlights connections between student perceptions of AI, academic integrity concerns and reported chatbot...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsValue

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers